Loading organizations...
§ Private Profile · Palm Beach Gardens, FL, USA
Medical device company developing and manufacturing spinal implants for minimally invasive spine surgery, focused on hospitals and ASCs.
Based in Palm Beach Gardens, Florida, Accelus is a medical device manufacturer that develops minimally invasive spine surgery technologies, including expandable spinal implants and surgical instrumentation. The company generates revenue through direct sales to hospitals and ambulatory surgery centers, reporting $27.5 million in annual revenue for 2021. Accelus has financed its operations through private equity rounds, including a $12 million Series D financing led by Concord Innovation Fund II, and previously called off a $482 million SPAC merger with CHP Merger Corp. In 2023, the organization sold its proprietary robotic navigation system to Surgalign Holdings to focus exclusively on its core spinal implant portfolio. Accelus was founded in 2021 through the merger of Integrity Implants and Fusion Robotics by co-founders Chris Walsh, Wyatt Geist, Alex Lukianov, Brad Clayton, and Dr. Kevin Foley.
Accelus has raised $32.0M across 2 funding rounds.
Accelus has raised $32.0M in total across 2 funding rounds.
Accelus has raised $32.0M across 2 funding rounds. Most recently, it raised $20.0M Debt in January 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 18, 2024 | $20M Debt Financing | Symbiotic Capital | — | Announced |
| Jul 15, 2022 | $12M Series D | Joseph R. Swedish | — | Announced |
Accelus has raised $32.0M in total across 2 funding rounds.
Accelus's investors include Symbiotic Capital, Joseph R. Swedish.